- Home
- ENTA vs MRT Comparison
ENTA vs MRT Comparison
Compare ENTA & MRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENTA
- MRT
- Stock Information
- Founded
- ENTA 1995
- MRT 2018
- Country
- ENTA United States
- MRT Turkey
- Employees
- ENTA N/A
- MRT N/A
- Industry
- ENTA Biotechnology: Pharmaceutical Preparations
- MRT Rental/Leasing Companies
- Sector
- ENTA Health Care
- MRT Consumer Discretionary
- Exchange
- ENTA Nasdaq
- MRT Nasdaq
- Market Cap
- ENTA 127.8M
- MRT 117.0M
- IPO Year
- ENTA 2013
- MRT N/A
- Fundamental
- Price
- ENTA $6.28
- MRT $2.95
- Analyst Decision
- ENTA Buy
- MRT
- Analyst Count
- ENTA 4
- MRT 0
- Target Price
- ENTA $19.50
- MRT N/A
- AVG Volume (30 Days)
- ENTA 537.1K
- MRT 184.0K
- Earning Date
- ENTA 02-05-2025
- MRT 01-01-0001
- Dividend Yield
- ENTA N/A
- MRT N/A
- EPS Growth
- ENTA N/A
- MRT N/A
- EPS
- ENTA N/A
- MRT N/A
- Revenue
- ENTA $67,635,000.00
- MRT $18,953,502.00
- Revenue This Year
- ENTA $11.80
- MRT N/A
- Revenue Next Year
- ENTA $3.99
- MRT N/A
- P/E Ratio
- ENTA N/A
- MRT N/A
- Revenue Growth
- ENTA N/A
- MRT N/A
- 52 Week Low
- ENTA $5.70
- MRT $0.51
- 52 Week High
- ENTA $17.80
- MRT $3.55
- Technical
- Relative Strength Index (RSI)
- ENTA 31.04
- MRT 54.85
- Support Level
- ENTA $5.70
- MRT $2.76
- Resistance Level
- ENTA $6.56
- MRT $3.27
- Average True Range (ATR)
- ENTA 0.74
- MRT 0.27
- MACD
- ENTA -0.11
- MRT -0.05
- Stochastic Oscillator
- ENTA 14.91
- MRT 24.05
About ENTA Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.
About MRT Marti Technologies Inc.
Marti Technologies Inc is a mobility app, operating a fleet of over 48,000 e-mopeds, e-bikes, and e-scooters, serviced by proprietary software systems and IoT infrastructure.